Furthermore, the current WHO HAEM5 lists EBV negativity as an essential criterion to establish the diagnosis of ALK-negative ALCL, indicating that EBV evaluation is now required to diagnose ALK-negative ALCL. This evidence concerns the gene ALK and anaplastic large cell lymphoma.